leisure time -WSS

leisure time

author：fashion 2025-09-29 22:50:17 - browse：6868

ANDREW YATES/AFP via Getty Images

In patients with stage 3 lung cancer where a particular genetic mutation is present in the tumor, taking AstraZeneca’s cancer-fighting pill Tagrisso reduced the chance that disease would progress by 84%.

“This will be practice changing as soon as this becomes available,” said David R. Spigel, chief scientific officer of the Sarah Cannon Research Institute at a press conference announcing the results at the annual meeting of the American Society of Clinical Oncology. “This will be how patients are treated wherever they can get access to this drug.”

Spigel but was not involved in the Tagrisso study but has relationships with multiple drugmakers including AstraZeneca.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Virtual Event: March of the Biosimilars

WSS

Methadone treatment changes are coming. Do they go far enough?

How faith leaders like me can help address America's obesity epidemic

Neuroscience’s long legacy of racism

ALS patient reclaims some autonomy thanks to wearable 'robot'

Virtual Event: March of the Biosimilars

Nurses recount patients attacks

hotspot

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

focus

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Baby aspirin cuts fat buildup in liver disease patients, in small study

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

How faith leaders like me can help address America's obesity epidemic

Virginia high school admissions case could be legal follow

Stephen Quake on the Chan Zuckerberg quest to conquer disease

At least 13 dead in Texas as scorching temps continue

Health AI adoption puts security, privacy startups on investors' radar

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Lilly's Alzheimer's drug donanemab backed by FDA advisers

hotspot

Health AI adoption puts security, privacy startups on investors' radar

Positive childhood experiences can help future health

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

App could help diagnose ear infections more accurately — and at home

Pharma companies must ensure equitable access to obesity drugs

Positive childhood experiences can help future health

Wikipedia

explore

focus

explore